REOTRAN-ES 250MG/250MG TABLET is endorsed to stop weighty dying. It fills in as an antifibrinolytic and hence prevents the blood coagulations from deteriorating exceptionally quick, which thus decreases dying. It is endorsed for momentary use (2 - 8 days) in hemophilia patients, during and following tooth extraction. This aides in the decrease or counteraction of drain. It is likewise utilized as an option to aminocaproic corrosive for subarachnoid discharge (SAH). Patients are by and large deterred from taking REOTRAN-ES 250MG/250MG TABLET on the off chance that they have/are: Hypersensitive to any part present in the medication An issue of blood clumps that are available in the cerebrum, eye, or lungs. Draining in light of a kidney issue or cerebrum issue. Experience unpredictable draining however its explanation has not set in stone As of now on anti-conception medication, similar to the pill or even the vaginal ring. This is principally on the grounds that such contraceptions contains estrogen along with progestin.